Identifying Predictors of Early Treatment Intensification in Individuals With Type 2 Diabetes Treated With GLP ‐1 Receptor Agonists: A Machine Learning–Based Analysis of a Large Real World Cohort

Pierpaolo Falcetta; Rita Zilich; Fabio Baccetti; Walter Baronti; Lelio Morviducci; Nicoletta Musacchio; Marco Muselli; Alessandro Ozzello; Federico Pisani; Antonio Rossi; Enrica Salomone; Damiano Verda; Riccardo Candido; Paola Ponzani

doi:10.1111/dom.70648

March 9, 2026Diabetes Obesity and Metabolism

Identifying Predictors of Early Treatment Intensification in Individuals With Type 2 Diabetes Treated With GLP ‐1 Receptor Agonists: A Machine Learning–Based Analysis of a Large Real World Cohort

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research aims to identify factors that predict early treatment intensification in individuals with Type 2 diabetes treated with GLP-1 receptor agonists.
Utilized explainable AI approaches for analysis
Focus on a large real-world cohort of individuals with Type 2 diabetes
Developed machine learning models to identify patient phenotypes
Identified distinct patient phenotypes associated with early treatment intensification
Models demonstrated reproducibility in predicting treatment adjustments
Findings suggest potential for more personalized treatment decisions in diabetes care

Implication

Exploratory analysis identifies predictors of personalized treatment intensification in Type 2 Diabetes, suggesting improved care strategies.

Abstract

Explainable AI identified a reproducible phenotype of patients associated with early intensification after GLP-1 RA initiation. These models may support earlier, more personalised treatment decisions in routine diabetes care.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Falcetta et al. (2026) studied this question.

synapsesocial.com/papers/69b25abe96eeacc4fcec8b7d https://doi.org/10.1111/dom.70648

View at Publisher

Ask AI

Bookmark

Share

Identifying Predictors of Early Treatment Intensification in Individuals With Type 2 Diabetes Treated With GLP ‐1 Receptor Agonists: A Machine Learning–Based Analysis of a Large Real World Cohort

Key Points

Implication

Abstract

Discussion

Cite This Study

Identifying Predictors of Early Treatment Intensification in Individuals With Type 2 Diabetes Treated With GLP ‐1 Receptor Agonists: A Machine Learning–Based Analysis of a Large Real World Cohort

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading